NASH

Hendrerit nunc sociis tortor condimentum purus pellentesque dictum.

Product Details

  • Non-alcoholic steatohepatitis (NASH), also known as metabolic steatohepatitis, is a clinical syndrome with pathologic changes similar to those of alcoholic hepatitis but without a history of excessive alcohol consumption, and is more common in middle-aged, especially overweight and obese individuals. NASH is closely related to metabolic disorders such as obesity, insulin resistance, type 2 diabetes, hyperlipidemia, etc. It is mainly characterized by hepatocellular vesicular steatosis with hepatocellular injury and inflammation, and in severe cases, it may develop into cirrhosis, for which there is no specific treatment. We have established stable multiple NASH models, which are suitable for preclinical NASH drug research and new drug evaluation. If you have a project need and experience more of our professional services, please contact us.
Disease NameModel nameSpecies of animals
MouseRatHamsterGuinea pigFerretRabbitCatDogPigNon-human primate
NASHDIO mouse NASH model
NASH model induced by ob/ob mice + high-fat diets
ob/ob mice + high fat and high cholesterol feed induced NASH model
NASH model induced by db/db mice + MCD chow
db/db+ high fat and high cholesterol feed induced NASH model
Model of NASH induced by high fat and high cholesterol feeds
Model of NASH induced by CDAA feed
Model of MCD feed-induced NASH
Model of NASH induced by a high-fat, high-cholesterol, high-fructose feed
NAFLD model induced by low-fat, high-fructose diets
NASH model induced by high-fat feed + 30% fructose water
High-fat feed + carbon tetrachloride-induced NASH model
Model of NASH induced by diethylnitrosamine (DEN) + high-fat, high-cholesterol feeds
Model of NASH induced by high-fat feed + streptozotocin (STZ)
Model of NASH induced by diethylnitrosamine (DEN) + streptozotocin (STZ) + high-fat, high-cholesterol feeds

Get A Quote